Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2250PDF: 1648HTML: 432 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2253PDF: 841HTML: 963Untitled: 279 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1155PDF: 1105HTML: 492 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
931PDF: 676Suppl. Files: 140HTML: 131 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2406PDF: 1205HTML: 985 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3806PDF: 1299HTML: 1732Untitled: 183 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2897PDF: 1043HTML: 5631 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1215PDF: 496HTML: 8249 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1410PDF: 1285HTML: 514 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1928PDF: 852HTML: 251 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2190PDF: 1590HTML: 650 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4538PDF: 1513HTML: 8530 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1130PDF: 799HTML: 149 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1358PDF: 770HTML: 403 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1590PDF: 579HTML: 865 -
-
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1927PDF: 817HTML: 3686 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3583PDF: 913HTML: 1671figure 1: 181Untitled: 207 -
-
Mantle cell lymphoma relapsing at the lymphedematous arm.
1741PDF: 712HTML: 3819 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5302PDF: 1553HTML: 1656Untitled: 247 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
4457PDF: 1052HTML: 475TABLE: 204FIGURES: 272 -
IMMUNOLOGY OF TUBERCULOSIS
5613PDF: 2060HTML: 7352Untitled: 209 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1902PDF: 870HTML: 1615 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
749PDF: 283Html: 36 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4027PDF: 1343HTML: 2493 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1106PDF: 1011Suppl. Files: 474HTML: 352







